Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Highly Accessed Research article

The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa

Zilungile L Mkhize-Kwitshana1*, Myra Taylor2, Pieter Jooste3, Musawenkosi LH Mabaso4 and Gerhard Walzl5

Author Affiliations

1 Offfice of the Deputy Dean: Postgraduate and Research, NRM School of Medicine, University of KwaZulu-Natal, P.O. Box 7, Congella, 4001, South Africa

2 Department of Public Health Medicine, University of KwaZulu-Natal, P.O. Box 7. Congella, 4001 South Africa

3 Nutritional Intervention Research Unit, P.O. Box 19070, Tygerberg, 7505, South Africa

4 HIV/AIDS, STI and TB, Human Sciences Research Council, Private Bag X07, Dalbridge, Durban 4014, South Africa

5 Department of Biomedical Sciences, University of Stellenbosch, Tygerberg, 7505, South Africa

For all author emails, please log on.

BMC Infectious Diseases 2011, 11:273  doi:10.1186/1471-2334-11-273


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/11/273


Received:9 July 2011
Accepted:14 October 2011
Published:14 October 2011

© 2011 Mkhize-Kwitshana et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The convergent distribution of the Human Immunodeficiency Virus (HIV) and helminth infections has led to the suggestion that infection with helminths exacerbates the HIV epidemic in developing countries. In South Africa, it is estimated that 57% of the population lives in poverty and carries the highest burden of both HIV and helmith infections, however, the disease interactions are under-researched.

Methods

We employed both coproscopy and Ascaris lumbricoides-specific serum IgE to increase diagnostic sensitivity and to distinguish between different helminth infection phenotypes and their effects on immune responses in HIV co-infected individuals. Coproscopy was done by formol ether and Kato Katz methods. HIV positive and negative adults were stratified according to the presence or absence of A. lumbricoides and/or Trichuris trichuria eggs with or without elevated Ascaris IgE. Lymphocyte subsets were phenotyped by flow cytometry. Viral loads, serum total IgE and eosinophils were also analysed. Lymphocyte activation markers (CCR5, HLA-DR, CD25, CD38 and CD71) were determined. Non parametric statistics were used to describe differences in the variables between the subgroups.

Results

Helminth prevalence ranged between 40%-60%. Four distinct subgroups of were identified, and this included egg positive/high Ascaris-specific IgE (egg+IgEhi), egg positive/low IgE (egg+IgElo), egg negative/high IgE (egg-IgEhi) and egg negative/low IgE (egg-IgElo) individuals. The egg+IgEhi subgroup displayed lymphocytopenia, eosinophilia, (low CD4+ counts in HIV- group), high viral load (in HIV+ group), and an activated lymphocyte profile. High Ascaris IgE subgroups (egg+IgEhi and egg-IgEhi) had eosinophilia, highest viral loads, and lower CD4+ counts in the HIV- group). Egg excretion and low IgE (egg+IgElo) status demonstrated a modified Th2 immune profile with a relatively competent response to HIV.

Conclusions

People with both helminth egg excretion and high Ascaris-IgE levels had dysregulated immune cells, high viral loads with more immune activation. A modified Th2 helminth response in individuals with egg positive stools and low Ascaris IgE showed a better HIV related immune profile. Future research on helminth-HIV co-infection should include parasite-specific IgE measurements in addition to coproscopy to delineate the different response phenotypes. Helminth infection affects the immune response to HIV in some individuals with high IgE and egg excretion in stool.

Background

The convergent distribution of the Human Immunodeficiency Virus (HIV) and helminth infections has been widely associated with the notion that persistent infection with helminths exacerbates the HIV epidemic in developing countries [1]. Chronic immune activation, altered immune cell distribution, immune suppression, altered cytokine profiles and strong T-helper 2 (Th2) bias induced by helminths, are suggested to increase susceptibility to the virus, enhancing its replication, increasing HIV disease severity and facilitating faster progression to AIDS [1,2]. The cellular and molecular immunological mechanisms of interaction reviewed in these papers [1,2], as well as many other epidemiological and immunological reports elsewhere and in Africa, provide sound suggestive evidence in support of the hypothesis [3-9].

South Africa (SA) has the highest number of HIV type 1 (HIV-1) infected individuals globally, about 5.6 million people out of a population of 48 million were living with HIV in 2010 [10]. Although the national estimates of helminth prevalence are not known, data from surveys in different SA provinces reveal infestation levels that range between 70-100% in school age children and preschoolers [11-17]. An estimated 57% of the SA population lives in poverty and carries most of the disease burden of the two infections [18,19]. However, studies that analyse the immunological interaction between these two disease conditions are limited in the country.

A major challenge in studies of co-infection with intestinal parasites is accurate laboratory diagnosis of the helminth infection, particularly in adults. In such studies, proper classification of helminth infection status is critical to avoid misinterpretation of results. It has been proposed that sole reliance on the presence of parasite eggs in stool to diagnose helminthiasis can lead to serious misinterpretation of results [20]. Maizels and Yazdanbakhsh [21] presented three phenotypic outcomes of helminth infection that are determined by antibody isotype (IgG4 and IgE) and T helper cell profiles. Each phenotype is characterised by specific immune responses to helminths. In the present study, stool egg detection has therefore been supplemented with serum Ascaris lumbricoides -specific IgE measurement. Four distinct subgroups, based on the presence or absence of stool eggs with or without elevated serum Ascaris-specific IgE were delineated. This paper reports the lymphocyte profiles including eosinophil counts, viral loads and the activation status in the defined subgroups.

Methods

Study design, setting and participants

Individuals in this study were a subgroup of adults (older than 18 years) from a larger prospective deworming study published in part elsewhere [20]. Ethical approval was obtained from the South African Medical Research Council and the University of Stellenbosch Ethics Committees. Permission to conduct the study was granted by the Matthew Goniwe Clinic management team. Written informed consent, which included permission to do HIV testing, was obtained from all participants.

The study was undertaken in Khayelitsha, Western Cape Province (SA), an informal settlement with limited resources, high helminth endemicity and HIV prevalence. A survey of 12 primary schools in this settlement showed that more than 90% of school children were infected by helminths [22], while a recall study on the history of helminth infection among adults showed that more than 70% had been infested by helminths previously [20]. Within the Western Cape Province, the prevalence of HIV in Khayelitsha (22%) was higher than the 9.1% provincial level [23].

Study participants were recruited from Mathew Goniwe clinic between May 2002 and November 2003 for the main study [20] and the present analyses commenced in August 2004 to November 2005. The HIV positive individuals were purposively recruited from the HIV Positive Support Group at the clinic, while the HIV negative were adults accompanying patients to the clinic. The selection criteria for the present study are outlined in Figure 1. All participants were antiretroviral therapy naive as such treatment was not routinely available to communities in SA at the time. To exclude recent and present infectious diseases and possible recent treatment for worms, the participants and case record files were examined by the study clinician and one-to-one interviews undertaken. Two stool samples, collected on two consecutive days, and approximately 30 ml of blood were obtained from each participant. Females provided fresh urine samples for β-HCG pregnancy screening.

thumbnailFigure 1. Selection strategy for inclusion of participants for immunological analyses. **Among the HIV- eligible participants, 23 did not submit the complete set of samples thus the remaining 22 were included by default.

Laboratory analyses

Detection of stool helminth eggs

Stool microscopy was performed by two independent microscopists using the formol-ether concentration [24] and the Kato Katz [25] methods respectively. Treatment with Mebendazole (and Praziquantel where indicated) was given to all participants with faecal helminth eggs. For this study, only participants infested with A. lumbricoides and/or T. trichiura were included.

HIV testing and viral loads

Confirmation of HIV status was done by a rapid test for HIV (InstantScreen® Rapid HIV-1/2 Assay GAIFAR GmbH, Germany) at the clinic. Serum was re-tested at Tygerberg Academic Hospital, Department of Virology using the Abbott Axsym® Microparticle Enzyme Immunoassay (MEIA) for the detection of antibodies to HIV-1 (subtypes M and O) and/or HIV-2. Confirmation of MEIA positive tests was done by PCR sequencing of viral DNA. HIV-1 viral load was determined by the Abbot LCx® HIV RNA Quantitative assay (Abbott Q1Laboratories, IL) in the same Virology department.

Full blood counts and serum IgE tests

Serum total and A. lumbricoides-specific IgE levels were determined by CAP total IgE and ImmunoCAP® Specific IgE (RAST), respectively. The cut-off for a positive Ascaris IgE test was > 0.35 ku/L, the assay detection limit. Full and differential blood counts were performed using the H2 Technicon Analyser at the Tygerberg Hospital Haematology laboratory on Ethylenediaminetetraacetic acid (EDTA) -anticoagulated whole blood. The full blood count results were used for the calculation of absolute lymphocyte subset numbers in the dual-platform analysis.

Four- Colour immunophenotyping of T cell subsets

Lymphocyte subsets were phenotyped by the MultiTest, four colour, direct immunofluorescence on the flourescence-activated cell sorter (FACS) Calibur™, Becton & Dickenson (BD) Biosciences, (San Jose, CA, USA). EDTA anticoagulated whole blood of 149 HIV-1 positive participants and 45 HIV-1 negative controls was stained with monoclonal antibodies (mAbs) to lymphocyte surface markers labelled with flourochromes as follows: Panel 1: CD45 Peridinin chlorophyll protein (PerCP); CD3 Flourescein Isothiocyanate (FITC); CD4 Allophycocyanin (APC); CD8 Phyco-erythrin (PE); Panel 2 CD3FITC;CD45 PerCP; CD19 APC; CD16+CD56 PE. All mAbs were obtained from Becton Dickinson (BD). Cells were stained within twenty four hours of blood collection using the standard procedure described in the BD MultiTest Reagent Package insert. Stained samples were analysed on the FACS Calibur™ (BD) Neon-Argon dual laser flow cytometer. For each sample, at least 10 000 events were acquired per tube using the MultiSET™ (BD) software. The percentages of each T and non-T lymphocyte subsets were determined. A double-platform method was then used to calculate the absolute counts of each lymphocyte subset from the total lymphocyte counts (from Haematology counts) and the lymphocyte percentages obtained by flow cytometry.

Peripheral blood mononuclear cell (PBMCs) preparation

PBMCs were separated by standard Ficoll Hypaque gradient centrifugation, suspended in fetal calf serum and 10% v/v Dimethylsulfoxide and cryopreserved in Liquid Nitrogen. Later, cells were thawed and counts were done by a phase-contrast microscope to simultaneously discriminate between viable and non-viable cells. Only samples with more than 90% viable cells were used.

Four-colour flow cytometric analysis of activation markers on PBMCs

Since the two chronic infections (HIV and helminths) result in sustained immune activation, hypothetically, upregulation of activation markers on peripheral lymphocytes would be more pronounced in co-infected individuals. To test this, the expression of CCR5, CD25, HLA-DR, CD38 and CD71 were determined on CD3+, CD4+ and CD8+ lymphocytes among HIV subgroups. These subgroups were randomly selected from all 124 HIV+ eligible participants (every second participant, using laboratory identifier numbers until there were 10 participants per subgroup). All the 22 HIV negative, eligible participants with or without helminth infections were included by default, for comparisons by HIV status.

PBMCs from 40 HIV-1 positive participants and 22 HIV negative controls were labelled with directly conjugated monoclonal antibodies to various surface activation markers to determine the ex-vivo activation status. The procedure described in the BD Biosciences/Pharmingen Catalogue [26] was modified for microtiter plates. Each sample was stained in five different wells containing combinations of mAbs to surface markers directly conjugated to fluorochromes as follows: CD3- PerCP; CD4-APC; CD8-, HLA-DR- and CD71 -FITC; CD8-, CD38-, CD25- and CCR5-PE. The following isotype controls (BD) were included: IgG1k and IgG2a- FITC; IgG1k and IgG2a -PE; IgG1k -PerCP and IgG2a -APC. All mAbs conjugates were purchased from BD. Stained cells were analysed on the FACS Calibur™ flow cytometer using BD FACS™ tubes. A minimum of 10 000 events were acquired for each sample tube in list mode using the Cellquest software (BD). Lymphocytes were gated on established regions and percentages of CD3, CD4 and CD8 cells expressing CCR5, CD25, HLA-DR and CD71 were quantified.

Statistical analysis

Statistical analysis was conducted in STATA version 10.0 (Stata Corporation, College Station, Texas, USA). The normal distribution of recorded data was tested by the Shapiro Wilks tests and variables with skewed data were log-transformed. As some of the variables remained skewed after this transformation non-parametric tests were used. The median was used as a measure of central tendency for descriptive statistics. Kruskal Wallis was used to test for differences in the medians and for multiple comparisons of all measured variables between the subgroups in HIV positive and HIV negative groups. A. p-value ≤ 0.05 was considered to be statistically significant.

Results

Of the 151 eligible, seropositive participants who submitted blood and stool samples, lymphocyte phenotypes were done on 149 individuals. Complete data for stratification of helminth infection was obtained for 124 individuals. Forty-five HIV negative participants submitted the samples and 39 were suitable for immunophenotypes and 22 could be stratified for helminthiasis. The demographic, viral and immunologic profile of the two HIV groups is summarized in Table 1. The reference ranges for the heamatological indices listed in this table had been established for the local population by the Tygerberg Hospital's Haematology Department. The local lower limits for CD4+ and CD8+ cells differ from those of the international reference ranges [27-29].

Table 1. Summary of baseline characteristics and haematologic indices of study participants by HIV status

Serum total IgE levels were 6-fold above the method reference range among the HIV-1 sero-positive people and 9-fold higher in the HIV-1 uninfected group while Ascaris-specific IgE was 6 times and 8 times higher in the two groups, respectively. The proportions by combined measures of high serum Ascaris-specific IgE plus stool egg positivity as indicators for helminth infection (>65%) exceeded the percentage of participants with stool egg positivity only (>40%) in both HIV positive and negative groups (Table 1). A range of parasites was detected in this adult population, including infection with more than one species. The most prevalent infections were A. lumbricoides (44 of the 51 HIV+ egg positive and 14 of 18 HIV- egg positive participants), followed by T. trichiura (30 of 51 HIV+ and 8 of 18 HIV- participants). Other parasites included the Taenia species (5 of 51 and 3 of 18 HIV+ and HIV- individuals respectively), Fasciola (one in each of the two HIV-1 groups) and Schistosoma mansoni (one of the 18 HIV-1 negatives). Among the HIV-1+, 21 of 51 (41%) were dually infected by A. lumbricoides and T. trichiura and 5 out of 18 (28%) among HIV- group harboured both these parasites. Worm burdens were lower in the HIV positive group.

Stratification of helminth infection subgroups by coproscopy and A. lumbricoides specific IgE (Ascaris IgE) serology

Some participants excreted parasite eggs with or without elevated A. lumbricoides IgE while others had high serum A. lumbricoides IgE but did not excrete eggs. Four distinct subgroups were stratified, among the HIV positive individuals. Subgroup 1 (n = 21) comprised of Trichuris and/or Ascaris egg positive stool and elevated Ascaris IgE (egg+IgEhi), a typical infection, subgroup 2 (n = 35) consisted of Trichuris and/or Ascaris egg positive stool without elevated Ascaris IgE (egg+IgElo), subgroup 3 (n = 21) contained Trichuris and Ascaris egg negative stool but elevated Ascaris IgE (egg-IgEhi), and subgroup 4 (n = 47) included Trichuris and Ascaris egg negative stool and low Ascaris IgE (egg-IgElo). Among the HIV negative participants the subgroups were egg+IgEhi (n = 9) egg+IgElo (n = 9), egg-IgEhi (n = 11) and egg-IgElo (n = 10).

Lymphocyte subsets, eosinophils and viral load in subgroups

Total lymphocyte numbers and their subpopulations (T, B, NK, CD4+ and CD8+), eosinophil counts and viral load were assessed in the four subgroups in HIV infected and uninfected participants (Tables 2 and 3).

Table 2. Comparison of eosinophils, viral load and lymphocytes among HIV positive subgroups

Table 3. Comparison of eosinophils and lymphocytes among HIV negative subgroups

HIV singly-infected (egg-lgElo) versus the HIV and typical helminth co-infected (egg+IgEhi) subgroup

The HIV-1+, egg-IgElo subgroup had the lowest CD4+ cells, T-lymphocyte counts and CD4:CD8 ratio than all the subgroups. In addition, there was no statistically significant difference between HIV+egg+IgEhi and the HIV+egg-IgElo subgroups in all measured variables except for eosinophils which were significantly higher in the dually infected individuals (Table 2).

HIV negative helminth uninfected (egg-IgElo) versus typical helminth infected (egg+IgEhi) subgroup

Higher but not statistically significant absolute counts for all T and non-T lymphocyte subsets were observed when the egg-gElo was compared to the typical helminth infected subgroup (egg+IgEhi). The egg-gElo subgroup had both marginally non significant higher total lymphocyte counts (p = 0.06) and lower eosinophils (p = 0.08). However, the CD4:CD8 ratio was higher in the egg+IgEhi subgroup.

Typical helminth (egg+IgEhi) and HIV co-infected subgroup

The HIV positive, egg+IgEhi subgroup had lymphocytopenia and statistically significant eosinophilia. Amongst the subgroups with evidence of dual infection, in the HIV positive egg+IgEhi group, the absolute values were lower for all lymphocyte populations, compared to the overall absolute counts for the entire HIV positive group (Table 1). The absolute values for all lymphocyte populations in the HIV positive egg+IgEhi subgroup were also lower compared to the egg+IgElo and the egg-IgEhi subgroups (Table 2).

B lymphocytes were significantly lower in the egg+IgEhi subgroup (p = 0.03) and CD4+ counts were marginally non-significantly lower (p = 0.06) compared to the egg+IgElo subgroup.

The egg+IgEhi status was associated with more frequent eosinophilia compared to the other three subgroups and this difference was highly significant (p = 0.01) between the egg+IgEhi subgroup and the egg-IgElo subgroup (no evidence of worm exposure) (Table 2). Furthermore, the median viral load for the egg+IgEhi subgroup was more than 2-fold higher than that of the combined HIV+ group shown in Table 1, and nearly 3-fold higher than those of the egg+IgElo and egg-IgElo subgroups (Table 2). These were however not statistically significant (p = 0.12).

HIV negative egg+IgEhi subgroup

The HIV negative, egg+IgEhi subgroup had lymphocytopenia and eosinophilia. As in the HIV positives, the HIV uninfected, egg+IgEhi participants had lower median values for all lymphocyte subsets except the CD4:CD8 ratio that was highest (Table 3). Total and B lymphocytes were significantly lower in the egg+IgEhi compared to the egg-IgEhi subgroup (p = 0.05). Furthermore, the egg+IgEhi subgroup had marked eosinophilia compared to the rest of the HIV-1 negative subgroups and the absolute eosinophil counts were higher in this egg+IgEhi group compared to both subgroups with low IgE(egg+IgElo) and the (egg-IgElo).

HIV positive Egg+IgElo subgroup

In the HIV positive group, the egg+IgElo participants had highest absolute numbers for all the lymphocyte subsets than all the other subgroups (Table 2), and also higher than the overall values for the entire HIV positive group shown in Table 1. There were significant differences in CD4+ (p = 0.01) and CD4:CD8 ratio (p = 0.03) between the egg+IgElo and the egg-IgElo subgroups. B lymphocyte values were significantly higher in the egg+IgElo compared to the egg+IgEhi subgroup (p = 0.02). Additionally, the egg+IgElo subgroup had the lowest viral load although this was not statistically significant (p = 0.12). However, a partially significant difference in viral load was observed between egg+IgElo and the egg-IgEhi subgroup (p = 0.05) when two extreme outliers are excluded from the analysis (Table 2).

HIV negative Egg+ IgElo subgroup

Similarly, in the HIV uninfected group, egg+IgElo participants appeared to have the highest total-, T-, CD8+-- and NK-lymphocyte counts. The total lymphocytes were significantly higher in this subgroup compared to the egg+IgEhi subgroup. The CD4+ and CD4:CD8 ratio was similar to the values for the egg-IgElo subgroup (without evidence of helminth infection) (Table 3).

HIV positive egg+IgEhi and egg-IgEhi (high IgE) subgroups

Among the HIV infected participants, both subgroups with elevated IgE (egg+IgEhi and egg-IgEhi) had the highest viral loads with 70 878 copies per ml (cpml) and 87 813 cpml respectively compared to the two subgroups with low Ascaris IgE egg+IgElo and egg-IgElo which had 25 666 cpml and 28 257 cpml, respectively. Although these differences in viral load were not statistically significant, the two subgroups with high IgE had almost three-fold higher viral loads. In addition to higher virus burden, the egg+IgEhi subgroup also had relatively higher eosinophil levels (Table 2).

HIV negative egg+IgEhi and egg-IgEhi subgroups

Likewise, among the HIV uninfected individuals, both groups with high IgE (egg+IgEhi and egg-IgEhi) had marked eosinophilia and lower CD4+ counts. Other observations in this section included the findings that low IgE (egg+IgElo and egg-IgElo) subgroups also had low eosinophil counts, particularly in the HIV uninfected groups (Table 3).

Viral loads and levels of immunodeficiency in subgroups

The maximum viral loads in each subgroup were 1 013 265 cpml (egg+IgEhi); 448 447 cpml (egg+IgElo); 1 711 249 cpm (egg-IgEhi) and 3 637 277 cpml (egg-IgElo). In the latter, three individuals had virus burden exceeding 1 000 000 cpml, and the individual with the highest viral load in the entire HIV group was found in this subgroup. The viraemia, determined by different grades of virus burden from 33 000 cpml (based on the median for all HIV positive study individuals) (Figure 2), and levels of immune deficiency, determined by CD4+ counts (Figure 3) were assessed in the four subgroups. The egg+IgEhi subgroup had the lowest number of individuals with high CD4+ counts and lowest proportion with low viral load. The egg+IgElo group had the highest number of individuals with higher CD4+ counts and lower viral loads (Figure 2 and Figure 3).

thumbnailFigure 2. Levels of viral loads (copies per ml of blood) in the four subgroups of HIV infected participants.

thumbnailFigure 3. Levels of immunodeficiency by CD4 counts (cells per ml of blood) in the four subgroups of HIV infected participants.

Immune Activation profile in HIV positive and HIV negative groups

HIV positive subgroups

Figure 4 illustrates interactions between the four subgroups of the 40 selected HIV positive participants. The egg+IgEhi subgroup had a statistically significant increased expression of all activation markers. When the HIV and helminth co-infected, egg+IgEhi subgroup was compared to the HIV-singly infected egg-IgElo subgroup, both had similar median CD4+ counts, which were slightly higher with 0.27 × 109/L cells in the former compared to 0.22 × 109/L cells in the egg-IgElo subgroup. The median viral load was significantly higher in the dually infected egg+IgEhi subgroup with 101 007 cpm compared to 4 234 cpm in the egg-IgElo subgroup (p = 0.01).

thumbnailFigure 4. Box and whisker plots for lymphocyte surface expression of activation markers in HIV+ subgroups, and Kruskal Wallis Anova comparison of medians for significant differences between subgroups (at p value ≤ 0.05), where Egg+IgEhi denotes helminth egg positive and elevated Ascaris lumbricoides IgE subgroup, Egg+IgElo represents egg positive and low A. lumbricoides IgE subgroup, Egg-IgEhi designates egg negative and high A. lumbricoides IgE subgroup, and Egg-Iglo stands for helminth egg negative and low A. lumbricoides IgE subgroup.

It is noted that the viral loads and CD4+ counts could not be matched before random selection of the subgroups. Comparisons of activation between these two subgroups showed that expression of all activation markers was almost two-fold higher in the egg+IgEhi subgroup. These results showed a significant difference between the egg+IgEhi helminth/HIV co-infected subgroup and the HIV-singly infected helminth non-infected (egg-IgElo) subgroup with regards to the level of immune activation.

Further analysis showed that the egg+IgEhi helminth/HIV co-infected subgroup expressed significantly higher levels of all activation markers than all the other subgroups in the HIV positive group (Figure 4). All these differences were statistically highly significant (p≤ 0.01) in all variables (Figure 4) except for CD4+CD25+ (p = 0.03). In this subgroup, median CD3+, CD4+ and CD8+ expression of the classic activation marker, HLA-DR, was higher than in all the other three subgroups (Figure 4 panels D-F, p≤ 0.01). In addition, median expression of CCR5 by CD8+ cells exceeded 90% while in CD4+ cells median CCR5 expression was almost twice as high as in the egg-IgEhi and the egg-IgElo subgroups.

Furthermore, the early activation marker-CD71 was 2-3 fold higher (p < 0.001) than in the other three subgroups in both the CD4+ and CD8+ compartments (Figure 4 Panels H and I). Almost all the CD8+ cells were CD38+ in this subgroup and this was statistically significantly higher (p = 0.01) than in the other subgroups (Figure 4, Panel G).

The highest levels of percentages of lymphocytes expressing all activation markers by the egg+IgE+ subgroup is remarkable in view of the fact that in the preceding section this egg+IgEhi group was shown to have a tendency towards a generalized reduction of lymphocyte populations.

In addition, stool egg positive subgroups (egg+IgEhi and egg+IgElo) had more than two-fold median CCR5 expression by CD4+ cells, compared to the stool egg negative subgroups (egg-IgEhi and egg-IgElo) in the HIV+ group. Furthermore, in both stool egg positive subgroups, median expression of CD38 by CD8+ lymphocytes exceeded 90% and this was statistically significant (Figure 4).

HIV negative subgroups

In the HIV- negative group, the egg+IgEhi subgroup had lower CD4+ counts compared to the other three subgroups. No dramatic increases in activation markers were observed among these individuals and no statistically significant differences were observed in any of the variables analysed except for the apparent increase (nearly two-fold) in median CD4+ CCR5+ in the egg+IgEhi and egg+IgElo subgroups (4.3% and 4.9%) compared to the egg-IgEhi and the egg-IgElo subgroups (2.2% and 2.4%) respectively. Likewise, expression of CCR5 on CD8+ cells was higher in the egg+IgEhi compared to the egg-IgEhi subgroup (p = 0.09). A marginally non-significantly higher CD8+ HLA-DR was also observed in the egg+IgElo compared to the egg-IgEhi subgroups (p = 0.09).

Discussion

In this study the combined use of coproscopy and serology not only improved the diagnosis of helminthiasis, but also facilitated the distinction of four phenotypically different infection profiles: (i) stool egg positive and high IgE (egg+IgEhi), (ii) the stool egg positive and low IgE (egg+IgElo), (iii) the stool egg negative and high IgE (egg-IgEhi) and (iv) the egg negative, IgE low (egg-IgElo) subgroups. Similarly, Maizels and Yazdanbakhsh [21] also described three phenotypic outcomes of helminth infections. In the present study, different forms of immune alterations and their possible effect on HIV infection were assessed within the defined subgroups.

Overall the prevalence of intestinal helminth infections was high (40-60%) in adults residing in this resource-limited study setting. Furthermore, the participants presented with a high IgE responder profile as shown by more than six-fold total and specific IgE above the reference ranges in both HIV+ and HIV- groups. This finding concurs with earlier suggestions that Africans generally present with elevated IgE levels as demonstrated in studies conducted in a similar ethnic group [30,31]. IgE class switching is mediated by CD4+ Th2 cells [32], and it is at present unclear whether the high IgE in this population is due to a genetic predisposition or environmental influences that mediate Th2 cell predominance.

The expected hypothetical study outcome was that dual infection would adversely impact on the immune profile of affected hosts compared to singly-or non-infected counterparts. Comparisons between singly and dually-infected HIV positive subgroups revealed no significant differences in lymphocyte profiles. There was significant eosinophilia in the HIV-helminth co-infected subgroup. In the absence of HIV infection, a tendency to increased lymphocytes and marginally lower eosinophils was observed in the egg-IgElo compared to the typical helminth infected egg+IgEhi subgroup. The differences in the other cell types were not statistically significant between these two groups. The relatively smaller numbers in the HIV negative subgroups could have influenced the power to obtain statistically significant differences. The fact that no such differences were noted in the HIV positive subgroups suggests that HIV-induced immunosuppression could be responsible for masking any differences in the latter. Firstly the HIV+, egg-IgElo subgroup had the lowest median CD4+ counts. Secondly, similar percentages of participants in the egg+IgEhi and egg-IgElo subgroups were severely immunocompromised (less than 0, 2 × 109 cells/L CD4+ counts) and virus burden was similar in the two subgroups (Figure 3).

When the dually-infected subgroups were analysed, several observations revealed that certain immunological phenoytypes of helminth infection may favour HIV replication, thus by inference lending support to the study hypothesis that helminthiasis might enhance virus replication. Firstly, typical helminth infection (as reflected by the egg+IgEhi status) was accompanied by eosinophilia, approximately three-fold higher viral loads and generally lower absolute counts for all lymphocyte populations when compared to the other three subgroups. This tendency was observed in both HIV positive and negative groups. This finding concurs with the report that chronic helminth infections in adults resulted in disruptions in peripheral T cell populations [33]. In addition, all measured activation markers were significantly elevated in the egg+IgEhi and HIV co-infected subgroup. Nearly all the CD8+ cells were CD38-positive in the egg+IgEhi subgroup (Figure 4). Immune activation has been widely implicated as playing a pivotal role in HIV pathogenesis through various pathways [1,2,34-36].

The observed decrease in lymphocyte populations among the egg+IgEhi individuals in this study, could indirectly relate to a compromised immunological ability to respond to HIV infection. Lymphocytes play a pivotal role in immune response to infection in general and in containing the HI virus [32]. Eosinophils are proposed to increase the number of activated cells that are infectable with HIV since they express the CD4 receptor molecule and in vitro studies showed that when these cells are activated, they can be infected by HIV [37,38]. These suggestions are in agreement with the study hypothesis and findings.

Furthermore, both subgroups with elevated IgE (egg+IgEhi and egg-IgEhi had eosinophilia, low CD4+ counts (especially in the HIV- group) and three-fold higher viral load (in HIV+group) compared to the low IgE subgroups (the egg+IgElo and egg-IgElo). Both eosinophilia and high IgE are classic Th2 responses that are universally induced by helminth infections [21,32]. The association of these mediators with higher viral loads supports the concept that Th2 polarisation by helminths suppresses the protective Th1 responses and hence promotes HIV replication [1,39,40].

In direct contrast to these responses of high IgE subgroups, the egg+IgElo subgroup had significantly higher absolute CD4+ counts and helper/suppressor ratios and generally higher absolute numbers of all lymphocyte subsets accompanied by the lowest viral load. This finding suggests a low IgE phenotype with a better ability to control the HIV viral infection in these individuals presenting as modified Th2 responders [21].

Several limitations are noted in this study. The cross sectional design was a major shortcoming as both HIV and helminth infections are chronic conditions. HIV infection has different stages, each characterised by different pathogenesis and immunologic features. Likewise, helminth infections have different life cycle phases that are associated with specific immune responses. Thus, an ideal design for studies of co-infections with these two organisms would be a prospective cohort study with randomised sampling. The small sample size also limited the study. The majority of participants were females in both HIV positive and negative groups and the HIV negative participants were slightly older (10 years difference in median ages) than the HIV positive group. Both age and gender may affect many immunological and haematological parameters [1]. These factors could possibly confound the study; nevertheless, it was encouraging to find some significant results despite the listed limitations.

Conclusions

Our results suggest that HIV immune responses are impaired by helminth infections in certain susceptible groups of individuals, particularly in individuals who excrete worm eggs and have high parasite IgE in serum. Helminth-induced Th2 bias is also associated with impaired immune response to HIV. Individuals with a modified Th2 response to helminths are better able to control HIV.

The present work contributes to the body of new knowledge in South Africa and provide evidence that the presence of intestinal parasite eggs in stools of infested individuals represents only a part of the helminth infection phenotype, which can be further delineated by levels of helminth-specific IgE (and IgG4) [21]. Grouping according to stool egg positivity alone would misclassify infection and non-infection; obscure the recognition of additional phenotypes with major implications for the interpretation of studies addressing immunological effects of co-infections with helminths. This has implications for the design of future studies aimed at analysing helminth co-infection and more importantly, interpretation of such studies. Parasite IgE serology should be used to supplement egg detection and delineate the different response phenotypes in future co-infection studies.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

ZLM-K: Involved during conceptualisation of the project, questionnaire design and field-testing, undertaking all immunological laboratory tests, collecting all data, analysing the results, intellectual input and writing the manuscript.MT: Co-supervisor for the project, Intellectual input, writing and critical editing of the manuscript. PJ: Critical reading of the manuscript. MLHM: Writing and critical editing of the manuscript. GW: Conceptualization of the project, intellectual input and supervision of the whole project and all the immunological work, writing of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank the South African Medical Research Council (SAMRC) for funding the project and the National Research Foundation for providing a travel grant for ZLM-K. We also thank the following individuals: Prof Terry Jackson, then Unit Director for Amoebiais Unit of the SA Medical Research Council (MRC), for facilitating financial support to ZL-MK for travel to Cape Town during laboratory analyses. Dr Ali Dhansay for clinical examination of patients and phlebotomy. Dr Justin Mwamba Clinician at the Mathew Goniwe Clinic for clinical assistance. Dr John Fincham, Ms Vera Adams and Ms Celia Anderson of the SAMRC's Amoebiasis-Helmithiasis Group for their technical support. We also thank Dr Lize van der Merwe of the SAMRC Biostatistics Unit for statistical advice. We are grateful to the Khayelitsha participants as well as the Matthew Goniwe HIV Positive Support Group for facilitating the interaction with the study participants.

References

  1. Borkow G, Bentwich Z: Chronic immune activation associated with chronic helminthic and Human Immunodeficency Virus infections: Role of hyporesponsiveness and anergy.

    Clinical Microbiology Reviews 2004, 17(4):1012-1030. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  2. Lawn SD, Butera S, Folks TM: The contribution of immune activation to the pathogenesis and transmission of Human Immunodeficiency Virus type1 infection.

    Clinical Microbiology Reviews 2001, 14(4):753-777. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  3. Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB: Filarial infections increase susceptibility to Human Immunodeficiency virus infection in peripheral blood mononuclear cells in vitro.

    The Journal of Infectious diseases 2000, 182:1804-1808. PubMed Abstract | Publisher Full Text OpenURL

  4. Clerici M, Butto S, Lukwiya M, Sarasella M, Declich S, Trabattoni D, Pastori C, Piconi S, Fracasso C, Fabiani M, Ferrante P, Rizzardini G, Lopalco L: Immune activation in Africa is enviromentally-driven and is associated with upregulation of CCR5.

    AIDS 2000, 14(14):2083-2092. PubMed Abstract | Publisher Full Text OpenURL

  5. Clerici M, Declich S, Rizzardini G: African enigma: key player in Human Immunodeficiency Virus pathogenesis in developing countries?

    Clinical and Diagnostic Laboratory Immunology 2001, 8(5):864-866. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  6. Rizzardini G, Trabattoni D, Saresella M, Piconi S, Lukwiya M, Declich S, Fabiani M, Ferrante P, Clerici M: Immune activation in HIV-infected African individuals: Italian-Ugandan AIDS cooperation program.

    AIDS 1998, 12(18):2387-2396. PubMed Abstract | Publisher Full Text OpenURL

  7. Secor WE, Shah A, Mwinzi PMN, Ndenga BA, Watta CO, Karanja DMS: Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4+ T cells and monocytes of patients with Schistosoma mansoni infection.

    Infection and Immunity 2003, 71(11):6668-6671. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  8. Shapira-Nahor O, Kalinkovinch A, Weisman Z, Greenberg Z, Nahmias J, Shapiro M, Panet A, Bentwich Z: Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals.

    AIDS 1998, 12:1731-1733. PubMed Abstract | Publisher Full Text OpenURL

  9. Malhotra I, Mungai P, Wamachi A, Kioko J, Ouma JH, Kazura JW: Helminth and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis.

    The Journal of Immunology 1999, 162:6843-6848. PubMed Abstract | Publisher Full Text OpenURL

  10. UNAIDS: [http://www.unaids.org/globalreport/Global_report.htm] webcite

    Report on the global AIDS Epidemic 2010.

    Accessed 22 January 2011

    OpenURL

  11. Evans AC, du Preez L, van der Merve CA, Schutte CHJ: Observations on the helminth infections in black pupils of the Eastern Transvaal Lowveld of South Africa.

    South African Journal of Epidemiology and Infection 1987, 2:7-14. OpenURL

  12. Fincham JE, Evans AC, Woodrof CW, Seager JR, Benade AJS, Appleton CC: Feed the children, not the parasites - an essential part of primary health care in South Africa.

    South African Medical Journal 1996, 86(6):647-649. PubMed Abstract OpenURL

  13. Mabaso MLH, Appleton CC, Hughes JC, Gouws E: Hookworm (Necator americanus) transmission in inland areas of sandy soils in KwaZulu-Natal, South Africa.

    Tropical Medicine & International Health 2004, 9(4):471-476. PubMed Abstract | Publisher Full Text OpenURL

  14. Saathoff E, Olsen A, Sharp B, Kvalsvig JD, Appleton CC, Kleinschmidt I: Ecologic covariates of hookworm infection and reinfection in rural KwaZulu-Natal/South Africa: a geographic information system-based study.

    American Journal of Tropical Medicine and Hygiene 2005, 72(4):384-391. PubMed Abstract | Publisher Full Text OpenURL

  15. Wolmarans CT, Bremond P, de Kock KN: The occurrence and distribution of schistosome intermediate hosts in relation to the prevalence of schistosome infections in humans in a highly endemic area in the Limpopo Province, South Africa.

    South African Journal of Epidemiology & Infection 2005, 20:18-22. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  16. Fincham J, Dhannsay A: Helminths in SA's children.

    MRC Policy brief 2006., 2 OpenURL

  17. Appleton CC, Mosala TI, Levin J, Olsen A: Goehelminth infection and re-infection after chemotherapy among slum-dwelling children in Durban, South Africa.

    Annals of Tropical Medicine & Parasitology 2009, 103(3):249-261. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  18. The Human Sciences Research Council Fact Sheet: Poverty in South Africa. [http://www.sarpn.org.za/documents/d0000990] webcite

    Southern African Regional Poverty Network 2004.

    Accessed 22 July 2010

    OpenURL

  19. Bradshaw D, Steyn K: Poverty and Chronic Diseases in South Africa.

    Technical Report 2001. South African Medical Research Council 2002. OpenURL

  20. Adams VJ, Markus MB, Kwitshana ZL, Dhansay MA, van der Merwe L, Walzl G, Fincham JE: Recall of intestinal helminthiasis by HIV-infected South Africans and avoidance of possible misinterpretation of egg excretion in helminth/HIV co-infection analyses.

    BMC Infectious Diseases 2006, 6(88):1-8. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  21. Maizels RM, Yazdanbakhsk M: Immune regulation by helminth parasites, cellular and molecular mechanisms.

    Nature Reviews Immunology 2003, 3:733-744. PubMed Abstract | Publisher Full Text OpenURL

  22. The Khayelitsha Task Team: Building health partnerships that work. Brochure published by the Khayelitsha Task Team 2001, Obtainable from the Medical Research Council, Cape Town, South Africa; OpenURL

  23. Shaikh N, Abdullah F, Lombard CJ, Smit L, Bradshaw D, Makubalo L: Masking through averages-intraprovincial heterogeneity in HIV prevalence within the Western Cape.

    South African Medical Journal 2006, 96(6):538-543. PubMed Abstract | Publisher Full Text OpenURL

  24. Ritchie LS: Ether sedimentation technique for routine stool examination.

    Bulletin of the US Army Medical Department 1948, 8:326. OpenURL

  25. Peters PA, El AM, Warren KS, Mahmoud AA: Quick Kato smear for field quantification of Schistosoma mansoni eggs.

    American Journal of Tropical Medicine and Hygiene 1980, 29:217-219. PubMed Abstract | Publisher Full Text OpenURL

  26. BD Biosciences/Pharmingen Product Catalog

    Technical Resources 2003. OpenURL

  27. Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

    MMWR Recomm Rep 1992, 41(RR-17):1-19. PubMed Abstract | Publisher Full Text OpenURL

  28. Word Health Organization: Antiretroviral Therapy for HIV infection in adults and adolescents: Recommendations for a Public Health Approach. WHO, Geneva; 2006. OpenURL

  29. AIDS Education & Training Centers (AETC), HIV Classification: CDC, WHO staging systems National Resource Center[http://www.aidsetc.org/aidsetc?page=cm-105_disease#t-2] webcite

    2006.

    Acessed 2 February 2007

  30. Gerrard JW: Genetic factors in the development of asthma. In Bronchial Asthma- Mechanisms and Therapeutics. 2nd edition. Edited by Weiss EEB, Segal MS and Stein M. Boston: Little Brown; 1985:24-29. OpenURL

  31. Haus M, Heese H, De V, Weinberg EG, Potter PC, Hall MJ, Malherbe D: The influence of ethnicity, an atopic family history and maternal ascariasis on cord blood serum IgE concentrations.

    Journal of Allergy & Clinical Immunology 1988, 82:179-189. PubMed Abstract | Publisher Full Text OpenURL

  32. Janeway CA, Travers P, Walport M, Shlomchik M: Immunobiology The immune system in health and disease. 5th edition. New York: Garland Publishing. Taylor & Francis Group; 2001. OpenURL

  33. Kalinkovinch A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, Stein M, Bentwich Z: Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

    Clinical and Experimental Immunology 1998, 114:414-421. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  34. Leng Q, Borkow G, Weisman Z, Stein M, Kalinkovich A, Bentwich Z: Immune activation correlates better than HIV plasma viral load with CD4 Tcell decline during HIV infection.

    Journal of Acquired Immune Deficiency Syndromes 2001, 27:389-397. PubMed Abstract | Publisher Full Text OpenURL

  35. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RMM, William EP: CD4 T cell depletion in HIV infection: are we closer to understanding the cause?

    Nature Medicine 2002, 8:319. PubMed Abstract | Publisher Full Text OpenURL

  36. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RMM: CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

    The Journal of Immunology 2002, 169:3400-3406. PubMed Abstract | Publisher Full Text OpenURL

  37. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF: Human eosinophils express CD4 protein and bind human immunodeficiency virus gp120.

    The Journal of Experimental Medicine 1989, 169:327-332. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  38. Freedman AR, Gibson FM, Fleming SC, Spry C J, Griffin GE: Human immunodeficiency virus infection of eosinophils in human bone marrow cultures.

    The Journal of Experimental Medicine 1991, 174:1661-1664. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  39. Clerici M, Shearer GM: The Th1-Th2 hypothesis of HIV infection: new insights.

    Immunology Today 2001, 12:575-581. OpenURL

  40. Kamal SM, El Sayed, Khalifa K: Immune modulation by helminthic infections: worms and viral infections.

    Parasite Immunology 2006, 28:483-496. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/11/273/prepub